News & Trends - Pharmaceuticals
AbbVie New Zealand welcomes new leadership as global moves unfold

Pharma News: AbbVie has announced the appointment of Elhussein Abdellatif as the new Country Head for New Zealand. Reporting directly to Nathalie McNeil, Vice President and General Manager of AbbVie Australia & New Zealand, Hussein brings a wealth of experience and expertise to his new role.
Hussein takes over from Kylie Pennington, who has been at the helm of AbbVie New Zealand since May 2022. Kylie has been appointed General Manager for Skyrizi Dermatology, International Marketing & Commercial Operations (IMCO), reporting to Felipe Palacios, VP, Immunology, IMCO.
With a degree in Pharmaceutical Science from Ain Shams University in Egypt and over 18 years of industry experience spanning various roles and therapeutic areas, including Immunology, Oncology, Neuroscience, and HCV, Hussein is well-equipped to lead the New Zealand team.
Having been with AbbVie for nine years, Hussein initially joined AbbVie Saudi Arabia in 2015, progressing through the ranks. His most recent role was as the Oncology Commercial Director, Intercontinental, based in the US. Prior to joining AbbVie, Hussein gained valuable experience at MSD, Lundbeck, and Novartis, where he held roles in sales and marketing.
Ms McNeil expressed enthusiasm about Hussein’s appointment, stating, “We are excited to have Hussein join and lead the New Zealand team to build on the strong foundations already in place. His promotion, along with Kylie’s promotion to a global role, demonstrates AbbVie’s commitment to developing key talent and creating compelling career opportunities. We also thank Kylie for her leadership over the past two years in the Country Head role.”
Hussein officially assumed his new role last month and is currently in the process of relocating from Chicago to New Zealand with his family. In a parallel move, Kylie Pennington and her family are also relocating, making the journey from Auckland to Chicago.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - MedTech & Diagnostics

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms
Hospitals shouldn’t be forced to grovel to private health insurers to secure funding for essential, lifesaving medical devices. But thanks […]
MoreNews & Trends - Pharmaceuticals

Oncologists pioneer liquid biopsy-guided treatment in lung cancer
Lung cancer is Australia’s leading cause of cancer deaths. Local experts are set to lead a new frontier in personalised […]
MoreMedical and Science

The high cost of record low research funding
Australia has delivered some of the world’s most transformative health and medical breakthroughs – the cochlear implant, the HPV vaccine, […]
MoreNews & Trends - Pharmaceuticals

UCB secures dermatology indication with first dual IL-17A/F inhibitor
UCB’s IL-17A and IL-17F inhibitor has been added to the Australian Register of Therapeutic Goods (ARTG) for adults with moderate […]
More